Flying cars for Oman and Syria's payment system recovery: This week's business headlines from the Middle East
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Daikin Applied Signs Agreement to Acquire DDC Solutions
New deal will add modular, ultra-high-density hybrid cooling solutions to Daikin Applied's portfolio of industry-leading technologies for data centers MINNEAPOLIS, Aug. 5, 2025 /PRNewswire/ -- Daikin Applied today announced it has entered into a definitive agreement to acquire DDC Solutions, a San Diego-based developer of ultra-high-density cooling cabinets and management software for data centers. This deal is subject to customary closing conditions, including the receipt of regulatory approvals under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, and is expected to close by month's end. The acquisition will expand Daikin Applied's data center-focused portfolio — adding in-room, rack-level solutions for white space cooling, and underscoring the company's commitment to providing complete data center cooling solutions. "The demand for high-performance data centers is accelerating and the equipment inside those data centers is evolving rapidly," said Yu Nishiwaki, Chief Operating Officer for Daikin Applied. "This acquisition allows us to deliver a rack-level cooling platform that is resilient, flexible and scalable, and able to support current and next-generation chip sets." "As the world's leading air-conditioning company, nobody knows cooling better than Daikin," said James Moe, Executive Vice President of Sales, Service and Solutions at Daikin Applied. "We've applied that expertise to data centers in the form of HVAC technologies that span from large-tonnage chillers to in-room air handlers. And now we're going further into the computer room to provide an even broader array of cooling solutions." DDC Solutions offers a patented, self-contained hybrid cooling system that integrates air and liquid cooling directly within the data center racks. Unlike traditional air-cooled or plenum-based systems, this design contains heat removal within the rack itself, which improves operational efficiency and eliminates the need for costly infrastructure modifications. In addition, the cabinets provide excellent fire and water protection and significantly reduce the data center's acoustic signature. They also come equipped with data center infrastructure management software for real-time monitoring and automated cooling adjustment on a per cabinet basis. "The ability to scale quickly across geographies with Daikin's resources is a game changer," said Keith Markley, Chief Executive Officer of DDC Solutions. "The global demand for data center solutions is expanding so quickly and being part of Daikin Applied will allow us to respond to this demand at an even greater level of excellence than before." After the closing, DDC Solutions will operate as a subsidiary of Daikin Applied with the full DDC Solutions leadership team remaining in their current roles. Lincoln International served as the exclusive financial advisor to DDC Solutions and its shareholders. For additional details on Daikin Applied, and its full range of commercial and industrial HVAC equipment and solutions, connect to Also, follow the company on LinkedIn for the latest on HVAC technology, services and trends. About DDC SolutionsDDC Solutions is a leader in data center cooling and management technology. Its complete data center cooling platform includes the patented S-Series v4 cabinet technology and its leading dynamic management software. The S-Series supports up to 100 kW air cooling and is liquid to the chip ready to enable ultra-high-density cooling in excess of 1MW per cabinet. DDC Solutions enables data centers to meet traditional workload requirements but also push beyond the limits of existing data center capabilities to support AI and HPC densities, reducing risk and lowering the total cost of ownership. About Daikin Applied AmericasDaikin Applied, a member of Daikin Industries, Ltd., designs and manufactures advanced commercial and industrial HVAC systems for customers around the world. The company's technology and services play a vital role in creating comfortable, efficient and sustainable spaces to work and live — and in delivering quality air to workers, tenants and building owners. Daikin Applied solutions are sold through a global network of dedicated sales, service and parts offices. For more information or to locate a Daikin Applied representative, visit or call 800-432-1342. Also, follow the company on LinkedIn for the latest on HVAC technology, services and trends. Media Contact:Aaron ParkerCommunications DirectorDaikin View original content to download multimedia: SOURCE Daikin Applied Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
New Jersey Innovation Institute Appoints Chrissy Buteas and Elisa Charters
NEWARK, N.J., Aug. 5, 2025 /PRNewswire/ -- New Jersey Innovation Institute (NJII), a subsidiary of the New Jersey Institute of Technology (NJIT), is pleased to announce the appointment of Chrissy Buteas and Elisa Charters to NJII's Board of Directors. Chrissy Buteas is the President & CEO of the HealthCare Institute of New Jersey (HINJ), which serves as the trade association for leading research-based biopharmaceutical and medical technology companies in New Jersey. Buteas has held significant leadership positions throughout her career, including VP of Government Affairs at Optimum, Chief Government Affairs Officer of the New Jersey Business & Industry Association (NJBIA), and President and CEO of the Home Care & Hospice Association of New Jersey. Her board service includes roles with Middlesex College, New Jersey Innovation Institute (NJII), Thanexus, Inc., the National Association of Corporate Directors (NACD-NJ), and several other organizations. Buteas holds an MPA from Rutgers University-Newark and a BA from Rowan University. Buteas stated, "New Jersey's innovation economy depends on strong collaboration among diverse partners—from academia and research institutions to private industry, state government, and economic development agencies. As HINJ works to strengthen the research ecosystem through ongoing partnerships, I am honored to have the chance to serve on the board of New Jersey Innovation Institute (NJII). Together, we will continue to advance our state's technology and innovation initiatives." Elisa Charters is a seasoned executive strategist with over 30 years of public-sector finance and transactional experience, specializing in the negotiations of major economic development and regional infrastructure. Her highlights include leading valuation of the Port Authority of NY & NJ's 23 million sq. ft. of mixed-use portfolio, managing acquisitions in the redevelopment of One World Trade Center post 9/11 and assessing revenue programs as Assistant Comptroller of Port Commerce. Charters transitioned from government to entrepreneurship, founding EAC Business International LLC and more recently Juegos AI Lab, focusing on application programming interfaces and agentic AI modeling. A passionate advocate for education and underserved communities, she co-founded Latina Surge National non-profit, scaling it from a grassroots organization to an international platform. Charters is an alumna of NJIT, holding dual degrees in Environmental Science, and a graduate degree in International Finance and Business from Columbia University. When asked about the future of NJII, Charters remarked, "The global AI race is progressing at extreme speed, and this is New Jersey's AI moment. NJII is our East Coast Gateway to transformative growth across key innovation sectors, uniquely supported by NJIT, our premiere R1 translational research institution. State-of-the-art technology and the most prepared technical workforce will forge economic advancement and quality of life in New Jersey for decades to come." NJII President, Michael Johnson, Ph.D., expressed enthusiasm about Buteas and Charters' appointments: "We are thrilled to welcome Chrissy Buteas and Elisa Charters to the NJII Board of Directors. Their extensive backgrounds in healthcare and economic development will be invaluable as we continue to drive innovation and foster collaboration across New Jersey's key sectors. Together, we will enhance our mission to accelerate technology and support our state's growth, ensuring New Jersey remains at the forefront of the innovation economy." Under Johnson's leadership, NJII has made significant strides, including the recent launch of the NJII Venture Studio, the state's seventh Strategic Innovation Center (SIC) focused on high technology and IT. NJII has also strengthened its role in workforce development by expanding training programs in cutting-edge fields such as AI, advanced manufacturing, and biotechnology, creating hands-on opportunities for students and professionals alike About NJII The New Jersey Innovation Institute (NJII) is a 501(c)(3) non-profit wholly owned by NJIT. Founded in 2014, NJII leverages the vast resources of an R-1 research university, deep industry and government partnerships, and a proven track record of building industry-centric ecosystems to accelerate technology, foster innovation, and drive workforce development. With over $330 million in revenue across four divisions—AI/ML, Defense, Entrepreneurship, and Healthcare. NJII delivers measurable economic impact across New Jersey and beyond. Learn more: About NJIT New Jersey Institute of Technology (NJIT) is the leading producer of technological talent and knowledge in New Jersey, serving as a nexus of innovation. NJIT is the only polytechnic university classified as an R1 (highest level) Carnegie Classification research university and is designated as both an Asian American and Hispanic-serving institution. The New York Times college ranking tool rates NJIT No. 1 nationally among all public universities for high alumni earnings, economic mobility, and academic profile. Additionally, NJIT is ranked among the top 100 universities in the country for alumni mid-career earnings and is recognized as a Best Value College by The Princeton Review. View original content to download multimedia: SOURCE New Jersey Innovation Institute
Forbes
41 minutes ago
- Forbes
3 Important Ways The Big Beautiful Bill Impacts US Innovation And R&D
Since the passage of the Tax Cuts and Jobs Act in 2017, there has been considerable tension and concern among companies heavily concentrated in innovation and R&D. The One Big Beautiful Bill Act, signed into law on July 4th, 2025, by President Trump alleviates some of these concerns. This article discusses the key innovation-related issues at play from the prior passage of the TCJA. I then discuss the three primary ways that the Big Beautiful Bill will impact innovation and R&D moving forward. Innovation And R&D Before The Big Beautiful Bill In the U.S., R&D expenses have typically been able to be immediately expensed as incurred, according to The Tax Adviser. This deduction allows companies to expense qualifying R&D activities (also known as specified research and experimentation (SRE)) for tax purposes, resulting in significant tax benefits. These tax benefits primarily come in the form of time value of money benefits, as they allow the company to take a tax deduction immediately, rather than capitalizing the costs and having to wait many years for the expense to be fully expensed. As shown by GBQ, these time value of money benefits can be material for most innovative firms. There are also natural benefits from a cash flow perspective. The TCJA changed this treatment considerably. Starting in 2022, companies must now capitalize and amortize their R&D expenses over five years for domestically sourced R&D and 15 years for R&D performed outside of the U.S. The Bipartisan Policy Center argues that this change 'threatens the survival of some small businesses that are research-intensive and not yet profitable.' For instance, a company trying to get off the ground might not be able to part with the cash flows and tax benefits of an R&D project for up to 15 years. 3 Key Ways The Big Beautiful Bill Affects Innovation And R&D The Big Beautiful Bill made a critical change to Section 174 of the Internal Revenue Code by allowing companies to immediately expense domestic R&D. As I previously discussed in a Forbes article, the change to expensing rules surrounding R&D is among the most impactful changes to businesses and corporations out of the entire Big Beautiful Bill. This change was celebrated widely across innovative industries as it now allows U.S. companies to have the innovation edge that they had previously grown accustomed to having. There are three critical impacts that the Big Beautiful Bill has on R&D: (1) The Big Beautiful Bill Allows For Immediate Expensing For Domestic R&D As discussed by Anchin, the Big Beautiful Bill now allows companies to immediately expense domestically-sourced R&D in the year in which the costs were incurred. This means that companies will no longer have to wait a full five years to recover all of their R&D costs, which is the rule that was enacted starting in 2022. However, the Big Beautiful Bill still allows companies to capitalize and amortize costs if they choose to do so. This act would mean that the company would choose the period length of the R&D project (or a period of at least 60 months) and amortize the costs over that period. This useful tool enables companies with financial flexibility to recognize costs and manage earnings as they see fit. (2) The Big Beautiful Bill Makes No Changes To Expensing For Foreign R&D While the immediate expensing of R&D accrues for domestic R&D, no such changes are being provided for foreign R&D. Notably, the TCJA requires foreign R&D to be expensed over 15 years, leading to significant costs for U.S. companies that house their R&D outside of the U.S. Even though the TCJA created an innovation wedge by allowing differential tax benefits for domestic versus foreign R&D, the Big Beautiful Bill has only grown the wedge by not requiring domestic R&D to be capitalized and amortized. According to RSM, these impacts are substantial to the point that companies will need to actively determine whether their foreign R&D should be moved back to the U.S. Given other R&D-related tax costs (i.e., the GILTI and BEAT tax provisions), companies will need to factor in this increased wedge of tax benefits for domestic versus foreign R&D. (3) Under The Big Beautiful Bill, Companies Can Retroactively Expense Domestic R&D From Prior Years While the capitalizing and amortizing effects from the TCJA took effect in 2022, the Big Beautiful Bill allows for the retroactive implementation of the expensing. This effect means that the domestic R&D costs that were capitalized and amortized in 2022, 2023, and 2024 can now be expensed. However, the way that these costs can be expensed depends primarily on the company's size. According to The Tax Foundation, eligible small businesses, defined as companies with annual gross receipts of $31 million or less for the prior three years, can amend prior returns and claim full deductions for the years 2022, 2023, and 2024. For all other firms, the capitalized and amortized R&D expenses can be spread out over the 2025 and 2026 tax years. This retroactive implementation means that many businesses (particularly those that rely on innovative activities) can expect cash windfalls by way of significant expensing of these activities. While the R&D expensing rules under the Big Beautiful Bill will significantly impact when and to what extent companies can expense their R&D costs, the law does not substantively change R&D tax credit rules. As companies will have significantly greater R&D tax benefits through immediate expenses, these tax law changes are expected to lead to significantly greater innovation outputs, resulting in lower costs for innovative activities. For instance, under the Big Beautiful Bill, companies will now be able to immediately expense their R&D leading to both increased tax and cash flow benefits. These benefits naturally make R&D cheaper, leading to innovative companies increasing their investments in innovation. However, these tax and cash flow benefits from the Big Beautiful Bill came with the caveat of an increased wedge between foreign and domestic R&D. Notably, companies with significant R&D activities overseas will not benefit as much from these tax law changes since they will have to continue amortizing foreign R&D over 15 years. Meanwhile, their competitors with more domestic innovation activities will receive considerable benefits under the new rules. Consequently, some companies will need to assess the financial implications of onshoring their R&D activities.
